RU 58668: Further in vitro and in vivo pharmacological data related to its antitumoral activity
Authors:
- G. PrévostGPG. Prévost
- 1 December 1996
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 59 (5-6) , 449-457
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude miceThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative GroupMelanoma Research, 1992
- Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinomaDigestive Diseases and Sciences, 1992
- A Phase II study of high dose tamoxifen in progressive, metastatic renal cellAnnals of Oncology, 1992
- The only true antiestrogen is no estrogenMolecular and Cellular Endocrinology, 1990
- Therapeutic potential of pure antioestrogens in the treatment of breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Cytostatic effect of antiestrogens in lymphoid cells: relationship to high affinity antiestrogen-binding sites and cholesterolBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Estrogen-Induced Factors of Breast Cancer Cells Partially Replace Estrogen to Promote Tumor GrowthScience, 1986